- Home
- UAN vs BMEZ Comparison
UAN vs BMEZ Comparison
Compare UAN & BMEZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UAN | BMEZ |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 936.9M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | UAN | BMEZ |
|---|---|---|
| Price | $112.39 | $15.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 29.3K | ★ 391.3K |
| Earning Date | 02-17-2026 | 01-01-0001 |
| Dividend Yield | 5.98% | ★ 8.71% |
| EPS Growth | ★ 141.96 | N/A |
| EPS | ★ 12.04 | 0.54 |
| Revenue | ★ $614,528,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $9.39 | $30.17 |
| Revenue Growth | ★ 16.52 | N/A |
| 52 Week Low | $63.45 | $12.93 |
| 52 Week High | $119.90 | $16.95 |
Technical Indicators
Market Signals| Indicator | UAN | BMEZ |
|---|---|---|
| Relative Strength Index (RSI) | 66.52 | 54.74 |
| Support Level | $96.25 | $15.11 |
| Resistance Level | $119.90 | $15.55 |
| Average True Range (ATR) | 3.67 | 0.23 |
| MACD | 1.16 | 0.02 |
| Stochastic Oscillator | 69.48 | 67.44 |
Price Performance
Historical ComparisonAbout UAN CVR Partners LP
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.
About BMEZ BlackRock Health Sciences Term Trust of Beneficial Interest
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.